- This event has passed.
Endpoints at #ASCO26
ASCO is where oncology pipelines get stress-tested in front of the entire world. Readouts can make or break big pharma strategies and reshape treatment paradigms overnight. Join Endpoints News and leading oncology researchers as we break down the science and data worth a second look. We’re examining new readouts, unpacking the most anticipated trials on deck and discussing the biggest themes in cancer research.
Agenda
11:00 AM – 11:25 AM ET: In conversation with Jeff Legos
We’ll sit down with Pfizer’s Chief Oncology Officer for an update after his first year on the job, and how he’s thinking through the pharma’s cancer pipeline.
11:30 AM – 11:55 AM ET: Catching KRAS
For decades, KRAS was an obvious target for cancer treatments. And for decades, it seemed like an undruggable target. But that started to change with the first approved KRAS therapies. Research took off, and now, new data on pancreatic cancer suggest a potential breakthrough. Join pioneers in the space for a conversation on recent progress and where the work goes next.
12:00 PM – 12:30 PM ET: Delivering excellence, close to home
Community oncology is the backbone of cancer care in the U.S., treating the majority of patients and ensuring care is delivered close to home in communities across the country. This panel will explore how community oncologists are navigating increasing clinical complexity while continuing to deliver high-quality, patient-centered care. The session will highlight what is working today — and what needs to evolve — to support and strengthen community oncology as a foundational component of the cancer care ecosystem.
Hosted by:
